HBLYX
Price
$14.84
Change
-$0.08 (-0.54%)
Updated
Jun 13 closing price
Net Assets
11.79B
MROSX
Price
$9.07
Change
-$0.06 (-0.66%)
Updated
Jun 13 closing price
Net Assets
181.78M
Interact to see
Advertisement

HBLYX vs MROSX

Header iconHBLYX vs MROSX Comparison
Open Charts HBLYX vs MROSXBanner chart's image
Hartford Balanced Income Y
Price$14.84
Change-$0.08 (-0.54%)
VolumeN/A
Net Assets11.79B
MassMutual 40/60 Allocation R5
Price$9.07
Change-$0.06 (-0.66%)
VolumeN/A
Net Assets181.78M
HBLYX vs MROSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HBLYX vs. MROSX commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLYX is a Buy and MROSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLYX has more cash in the bank: 11.8B vs. MROSX (182M). HBLYX pays higher dividends than MROSX: HBLYX (3.53) vs MROSX (3.26). HBLYX was incepted earlier than MROSX: HBLYX (19 years) vs MROSX (14 years). MROSX (0.69) and HBLYX (0.67) have similar cost to investors . MROSX has a lower initial minimum investment than HBLYX: MROSX (0) vs HBLYX (250000). MROSX annual gain was more profitable for investors over the last year : 5.99 vs. HBLYX (4.74). HBLYX return over 5 years is better than : 17.48 vs. MROSX (12.81).
HBLYXMROSXHBLYX / MROSX
Total Expense Ratio0.670.6997%
Annual Report Gross Expense Ratio0.670.6997%
Fund Existence19 years14 years-
Gain YTD4.0813.657112%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B182M6,484%
Annual Yield % from dividends3.533.26108%
Returns for 1 year4.745.9979%
Returns for 3 years16.7016.76100%
Returns for 5 years17.4812.81136%
Returns for 10 years40.0919.00211%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZNAX11.06-0.07
-0.63%
Virtus Income & Growth A
FBTCX20.46-0.13
-0.63%
Fidelity Advisor Biotechnology C
MSCUX11.89-0.15
-1.25%
Morgan Stanley American Resilience A
NGRRX33.08-0.43
-1.28%
Nuveen International Value I
MNHCX25.58-0.40
-1.54%
Manning & Napier Pro-Blend Max Term L